AUGMENTATION OF THE STERILIZING EFFECT OF NEONATAL ANDROGENIZATION WITH TROPOLONE, A CATECHOL-O-METHYLTRANSFERASE INHIBITOR, IN FEMALE RATS

被引:4
|
作者
REZNIKOV, AG
NOSENKO, ND
TARASENKO, LV
机构
关键词
androgen; catechol-O-methyltransferase; catecholamines; hypothalamus; sexu al differentiation;
D O I
10.1159/000125628
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The influence of tropolone, a catechol-O-methyltransferase (COMT) inhibitor, on the sterilizing effect of neonatal testosterone propionate (TP) has been studied in Wistar female rats. Tropolone-induced changes in COMT activity and noradrenaline (NA) and dopamine (DA) contents in the hypothalamus have been evaluated. Inhibition of COMT activity was maximal 3 h after a single injection of 0.6 mg tropolone on postnatal day 5. An increase in DA level was observed 6 h after drug injection, whereas the NA content was elevated 24 h after tropolone administration. A sexual dimorphism in hypothalamic NA content in rats was found on postanatal day 10: it was higher in males than in females. The rise of catecholamines in the hypothalamus of 10-day-old female rats induced by COMT inhibition with tropolone (0.3 mg on postnatal days 5 and 7) was unable to masculinize developing neuroendocrine regions responsible for sexual cyclicity. At the same time, combined administration of tropolone (0.1 mg daily on postnatal days 4-10) and TP (0.025 mg on day 4) enhanced the sterilizing effect of the androgen. An anovulatory sterility appeared in all experimental animals. It is suggested that a cooperative interaction occurs between catecholamines and sex steroids as determinants of brain sexual differentiation.
引用
收藏
页码:455 / 459
页数:5
相关论文
共 50 条
  • [31] Entacapone:: A catechol-O-methyltransferase inhibitor for the adjunctive treatment of Parkinson's disease
    Najib, J
    CLINICAL THERAPEUTICS, 2001, 23 (06) : 802 - 832
  • [32] Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-methyltransferase
    Kiss, Laszlo E.
    Ferreira, Humberto S.
    Torrao, Leonel
    Bonifacio, Maria Joao
    Palma, P. Nuno
    Soares-da-Silva, Patricio
    Learmonth, David A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (08) : 3396 - 3411
  • [33] Catechol-o-methyltransferase inhibitor tolcapone alleviates lipopolysaccharide induced memory impairment
    Mihaylova, A.
    Doncheva, N.
    Zlatanova, H.
    Delev, D.
    Kostadinov, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S399 - S400
  • [34] EVIDENCE THAT 6-HYDROXYDOPAMINE IS AN INHIBITOR OF CATECHOL-O-METHYLTRANSFERASE IN INTACT TISSUE
    REID, JJ
    STITZEL, RE
    HEAD, RJ
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1986, 38 (01) : 46 - 51
  • [35] Integrated Mass Spectrometry Reveals Celastrol As a Novel Catechol-O-methyltransferase Inhibitor
    Guo, Haijun
    Yang, Yang
    Zhang, Qi
    Deng, Jie-Ren
    Yang, Ying
    Li, Shuqi
    So, Pui-Kin
    Lam, Thomas C.
    Wong, Man-kin
    Zhao, Qian
    ACS CHEMICAL BIOLOGY, 2022, 17 (08) : 2003 - 2009
  • [36] Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder
    Fava, M
    Rosenbaum, JF
    Kolsky, AR
    Alpert, JE
    Nierenberg, AA
    Spillmann, M
    Moore, C
    Renshaw, P
    Bottiglieri, T
    Moroz, G
    Magni, G
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (04) : 329 - 335
  • [37] POTENTIATION OF CENTRAL EFFECTS OF L-DOPA BY AN INHIBITOR OF CATECHOL-O-METHYLTRANSFERASE
    NUUTILA, J
    KAAKKOLA, S
    MANNISTO, PT
    JOURNAL OF NEURAL TRANSMISSION, 1987, 70 (3-4) : 233 - 240
  • [38] Tolcapone, a selective catechol-O-methyltransferase inhibitor for treatment of Parkinson's disease
    Guay, DRP
    PHARMACOTHERAPY, 1999, 19 (01): : 6 - 20
  • [39] BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF A PERIPHERALLY ACTING CATECHOL-O-METHYLTRANSFERASE INHIBITOR ENTACAPONE
    NISSINEN, E
    LINDEN, IB
    SCHULTZ, E
    POHTO, P
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1992, 346 (03) : 262 - 266
  • [40] IDENTIFICATION OF MAJOR METABOLITES OF THE CATECHOL-O-METHYLTRANSFERASE INHIBITOR NITECAPONE IN THE RAT AND DOG
    WIKBERG, T
    TASKINEN, J
    DRUG METABOLISM AND DISPOSITION, 1993, 21 (02) : 325 - 333